Reproductive effects of the psychoactive beverage ayahuasca in male Wistar rats after chronic exposure
Alana de Fátima Andrade Santos, Ana Luiza Sarkis Vieira, Aline Pic‐taylor, Eloísa Dutra Caldas
Revista Brasileira de Farmacognosia March 9, 2017 DOI: 10.1016/j.bjp.2017.01.006 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Animal study Peer reviewed |
|---|---|
| Sample size | 60 |
| Population | Male Wistar rats |
| Intervention | Ayahuasca |
| Dose | 0 (control), 1, 2, 4 and 8 times the dose used in a religious ritual |
| Duration | 70-day intervention, euthanized on day 71 |
| Topics | Ayahuasca |
| Keywords | Epididymis Sperm Harmaline Testosterone patch Stomach Body weight Physiology Endocrinology |
| Citations | 19 |
| Key points | Chronic ayahuasca at four times the ritualistic dose increased serum testosterone and reduced epididymal sperm reserves and transit time, with a no-observed-adverse-effect-level at twice the ritualistic dose. |
Abstract
Ayahuasca is a psychoactive beverage used ancestrally by indigenous Amazonian tribes and, more recently, by Christian religions in Brazil and other countries. This study aimed to investigate the reproductive effects of this beverage in male Wistar rats after chronic exposure. The rats were treated by gavage every other day for 70 days at 0 (control), 1, 2, 4 and 8 the dose used in a religious ritual (12 animals per group), and animals euthanized on the 71 st day. Compared to controls, there was a significant decrease in food consumption and body weight gain in rats from the 4 and 8 groups, and a significant increase in the brain and stomach relative weight at the 8 group. There was a significant increase in total serum testosterone, and a decrease in spermatic transit time and spermatic reserves in the epididymis caudae in the 4 group, but not in the highest dose group. No significant changes were found in the other reproductive endpoints (spermatozoid motility and morphology, total spermatozoid count and daily sperm production), and histology of testis and epididymis. This study identified a no-observed-adverse-effect-level for chronic and reproductive effects of ayahuasca in male Wistar rats at 2 the ritualistic dose, which corresponds in this study to 0.62 mg/kg bw N,N-dimethyltryptamine, 6.6 mg/kg bw harmine and 0.52 mg/kg bw harmaline. A potential toxic effect of ayahuasca in male rats was observed at the 4 dose, with a non-monotonic dose-response. Studies investigating the role of ayahuasca components in regulating testosterone levels are needed to better understand this action.
Comparable studies
Other preclinical and animal studies on ayahuasca, most cited first.
Citations in the library
Cited by 14
- Chronic, Intermittent Microdoses of the Psychedelic N , N -Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents ACS Chemical Neuroscience March 4, 2019
- Toxicity of ayahuasca after 28 days daily exposure and effects on monoamines and brain-derived neurotrophic factor (BDNF) in brain of Wistar rats Metabolic Brain Disease February 27, 2020
- The risk of chronic psychedelic and MDMA microdosing for valvular heart disease Journal of Psychopharmacology August 12, 2023
- Toxicological Aspects and Determination of the Main Components of Ayahuasca: A Critical Review Medicines October 18, 2019
- Exposure to ayahuasca induces developmental and behavioral alterations on early life stages of zebrafish Chemico-Biological Interactions August 4, 2018
and 9 more in the library
Cites 23
- Monoamine oxidase inhibitors in South American hallucinogenic plants: Tryptamine and β-carboline constituents of Ayahuasca Journal of Ethnopharmacology April 1, 1984
- Human Pharmacology of Ayahuasca: Subjective and Cardiovascular Effects, Monoamine Metabolite Excretion, and Pharmacokinetics Journal of Pharmacology and Experimental Therapeutics June 18, 2003
- Human Psychopharmacology of Hoasca, A Plant Hallucinogen Used in Ritual Context in Brazil The Journal of Nervous and Mental Disease February 1, 1996
- Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges. Pharmacology & Therapeutics May 1, 2004
- The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. European Journal of Pharmacology March 22, 2007
and 18 more in the library